A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.
https://twitter.com/ClearGuide/status/720990472647360512
The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals. The startup is looking to expand sales in the U.S. and Europe.
Clear Guide Medical closes $1.5 million Series A
And another $1.5 million could be on the way. The startup’s biopsy imaging tools also have FDA approval.
